Pancreatic Cancer Research

ResearcherJohannes Kepler University of LinzActive in the last 2 years

Stefan Stättner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5226-7597; OpenAlex author ID A5082720581. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
  2. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
  3. Pancreatic cancer. Last author DOI 10.1016/j.ejso.2023.01.001↗
  4. Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients. Co-author DOI 10.2144/fsoa-2020-0128↗
  5. Pancreatic cancer in young adults: changes, challenges, and solutions. First author DOI 10.2147/ott.s176700↗
  6. Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review. Co-author DOI 10.3892/ijo.2013.2176↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elena B. Rangelova · 1 shared paper, 2023 · strength 0.24
  2. Kjetil Søreide · 1 shared paper, 2023 · strength 0.24
  3. Konstantin Schlick · 2 shared papers, 2019–2020 · strength 0.20
  4. Florian Hohla · 2 shared papers, 2014–2020 · strength 0.14
  5. Gabriel Rinnerthaler · 2 shared papers, 2014–2020 · strength 0.14
  6. Richard Greil · 2 shared papers, 2014–2020 · strength 0.14
  7. Florian Primavesi · 1 shared paper, 2019 · strength 0.10
  8. Daniel Neureiter · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.